GATC Health Joins Critical Path Institute’s New Approach Methodologies Developer Coalition to Advance AI-Enabled Regulatory Science

GATC will contribute AI-native in silico drug-discovery and predictive-modeling expertise to a collaborative effort focused on validating, qualifying and expanding adoption of human-relevant drug-development tools. The initiative could support more efficient preclinical development, but the announcement provides no financial terms, timeline or quantified commercial impact.